UY30205A1 - Derivados de cromano, sales del mismo farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones - Google Patents

Derivados de cromano, sales del mismo farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones

Info

Publication number
UY30205A1
UY30205A1 UY30205A UY30205A UY30205A1 UY 30205 A1 UY30205 A1 UY 30205A1 UY 30205 A UY30205 A UY 30205A UY 30205 A UY30205 A UY 30205A UY 30205 A1 UY30205 A1 UY 30205A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutically acceptable
compositions containing
salts
reflux
applications
Prior art date
Application number
UY30205A
Other languages
English (en)
Inventor
Tatsuya Yamagishi
Yukari Matsumoto
Hikoharu Shimokawa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY30205A1 publication Critical patent/UY30205A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos de formula (I): o sus sales farmacéuticamente aceptable, donde R1, R2, R3, R4, R5, R6, R7, R8 a y b son como se definen en la memoria, composiciones conteniéndolos utiles para tratamiento de afeccion mediada por actividad antagonista de bomba de ácido, tales como, pero no limitado a, enfermedades gastrointestinal, gastroesofágica, reflujo gastroesofágico (ERGE), reflujo laringofaríngeo, ulcera péptica, ulcera gástrica, ulcera duodenal, ulceras inducidas por AINE, gastritis, infeccion por Helicobacter pylori, dispepsia, dispepsia funcional, síndrome de Zollinger-ellison, reflujo no erosivo (ERNE), dolor visceral, cáncer, acidez, náuseas, esofagitis, disfagia, hipersalivacion, trastornos de las vías aéreas y asma.
UY30205A 2006-03-17 2007-03-14 Derivados de cromano, sales del mismo farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones UY30205A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78366306P 2006-03-17 2006-03-17
US80487206P 2006-06-15 2006-06-15

Publications (1)

Publication Number Publication Date
UY30205A1 true UY30205A1 (es) 2007-10-31

Family

ID=38255490

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30205A UY30205A1 (es) 2006-03-17 2007-03-14 Derivados de cromano, sales del mismo farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones

Country Status (15)

Country Link
US (1) US20070219237A1 (es)
EP (1) EP1996589A1 (es)
JP (1) JP2009530262A (es)
KR (1) KR20080108129A (es)
AR (1) AR059903A1 (es)
BR (1) BRPI0708808A2 (es)
CA (1) CA2645007A1 (es)
GT (1) GT200700022A (es)
MX (1) MX2008011044A (es)
NL (1) NL2000532C2 (es)
PE (1) PE20071313A1 (es)
RU (1) RU2008137145A (es)
TW (1) TW200804380A (es)
UY (1) UY30205A1 (es)
WO (1) WO2007107827A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR077688A1 (es) 2009-08-04 2011-09-14 Takeda Pharmaceutical Compuestos heterociclicos, utiles en el tratamiento de cancer
CA2929858C (en) 2013-11-22 2022-03-29 CL BioSciences LLC Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis
KR101769204B1 (ko) * 2015-08-04 2017-08-17 씨제이헬스케어 주식회사 크로마놀 유도체의 신규한 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191164B1 (en) * 1996-05-15 2001-02-20 Hoechst Aktiengesellschaft Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
JP2003528097A (ja) * 2000-03-17 2003-09-24 ブリストル−マイヤーズ スクイブ ファーマ カンパニー マトリックスメタロプロテアーゼおよびＴＮＦ−α阻害剤としてのβ−アミノ酸誘導体
EP1283039A4 (en) * 2000-05-19 2007-05-30 Takeda Pharmaceutical INHIBITORS OF -SECRETASE
JP4145654B2 (ja) * 2001-01-26 2008-09-03 塩野義製薬株式会社 トロンボポエチン受容体アゴニスト作用を有する環状化合物
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
EP1565465A1 (en) * 2002-11-19 2005-08-24 ALTANA Pharma AG 8-substituted imidazopyridines
ES2313444T3 (es) * 2004-12-17 2009-03-01 Raqualia Pharma Inc Derivados de cromano utiles como antagonistas de la bomba de acido.

Also Published As

Publication number Publication date
NL2000532A1 (nl) 2007-09-18
PE20071313A1 (es) 2008-01-25
NL2000532C2 (nl) 2008-02-05
RU2008137145A (ru) 2010-03-27
MX2008011044A (es) 2008-10-09
KR20080108129A (ko) 2008-12-11
JP2009530262A (ja) 2009-08-27
GT200700022A (es) 2008-02-05
US20070219237A1 (en) 2007-09-20
TW200804380A (en) 2008-01-16
BRPI0708808A2 (pt) 2011-06-14
WO2007107827A1 (en) 2007-09-27
AR059903A1 (es) 2008-05-07
EP1996589A1 (en) 2008-12-03
CA2645007A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
DOP2006000285A (es) Derivados de bencimidazol sustituidos con cromano
ATE512969T1 (de) Benzimidazolderivate als selektive säurepumpenhemmer
ATE442140T1 (de) Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten
NZ591793A (en) Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds
RU2015122126A (ru) Производное пиррол сульфонамида, метод его получения и применение в медицине
EE04279B1 (et) Omeprasooli kristalne vorm
NZ734896A (en) Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
EA201200741A1 (ru) Способ получения этексилата дабигатрана
CY1108024T1 (el) Αλατα αλκυλαμμωνιου ομεπραζολης και εσομεπραζολης
RU2007138053A (ru) Производное бензимидазола
BR0211101A (pt) Processo melhorado para preparação de compostos tipo benzimidazol
CL2009000547A1 (es) Forma cristalina de (r)-2[[[3-metil-4-(2,2,2-trifluoroetoxi)-2-piridinil]metil]sulfinil]-1h-bencimidazol, metodo de preparacion; composicion farmaceutica y su uso para la profilaxis o tratamiento de ulcera peptica, gastritis, esofagitis erosiva, esofago de barret,dispepsia funcional, cancer gastrico.
UY30205A1 (es) Derivados de cromano, sales del mismo farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones
CY1113148T1 (el) Χρηση υποκατεστημενων παραγωγων πυρανονικου οξεος για τη θεραπευτικη αντιμετωπιση του μεταβολικου συνδρομου
CY1113129T1 (el) Παραγωγα 5,6-δισαρυλ-2- πυριδινο- καρβοξαμιδιου, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη ως ανταγωνιστες των υποδοχεων ουροτενσινης ii
NO20072764L (no) Kromanderivater som er nyttige syrepumpeantagonister
EA201000340A1 (ru) Аминобензилзамещенные циклические сульфоны, полезные в качестве ингибиторов васе
ITMI20021861A1 (it) Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
JP2008524199A5 (es)
WO2007072142A3 (en) Benzimidazole-5-carboxamide derivatives
WO2007026218A3 (en) Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
PE20080654A1 (es) Amidas con dos sustituyentes aromaticos como inhibidores del glyt1
ATE499446T1 (de) Optisch aktiven cyclopentenonen zur herstellung von prostaglandinen
PE20091776A1 (es) 4-butiratos de trimetilamonio como inhibidores de la cpt2
WO2014147541A3 (en) Compounds and compositions for the treatment of peptic ulcers and gastrointestinal diseases

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170531